The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility

Journal of Chemotherapy

Volumn 26, Issue 2, 2014, Pages 125-128

  Helal, Soheir Fathy ^a   El Rachidi, Nevine Gamal Eldin ^a   AbdulRahman, Eiman Mohammed ^a   Hassan, Dina Mohammed Ahmed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAMASE AMPC; CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; RESTRICTION ENDONUCLEASE; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

AGAR GEL ELECTROPHORESIS; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CONTROLLED STUDY; DISK DIFFUSION; EGYPT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOTE; PHENOTYPE; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; BIOSYNTHESIS; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; MICROBIOLOGY;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; EGYPT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; KLEBSIELLA PNEUMONIAE;

EID: 84895784546     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947813Y.0000000099     Document Type: Note

References (19)

1. Hoenigl M, Valentin T, Zarfel G, Wuerstl B, Leitner E, Salzer HJF, et al. Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemas-producing Klebsiella oxytoca in Austria. Antimicrob Agents Chemother. 2010;56(4):2158-61.
2. Chu YW, Tung VWN, Cheung TKM, Chu M, Cheng N, Lai C, et al. Carbapenemases in enterobacteria, Hong Kong, China. Emerg Infect Dis. 2009;17:130-2.
3. Cuzon G, Naas T, Truong H, Villegas M, Wisell KT, Carmeli Y, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis. 2010;16:1349-56.
4. Chen LF, Anderson DJ, Paterson DL. Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance. Infect Drug Resist. 2012;5:133-41.
5. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151-61.
6. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemases in Gramnegative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010;16:112-22.
7. Clinical and Laboratory Standards Institute 2010: Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Document M100-S29. Wayne, PA.
8. Benenson S, Temper V, Cohen MJ, Schwartz C, Hidalgo-Grass C, Block C. Imipenem Disc for Detection of KPC Carbapenemase-Producing Enterobacteriaceae in Clinical Practice. J Clin Microbiol. 2011;49(4):1617-20.
9. Cole JM, Schuetz AN, Hill CE, Nolte FS. Development and evaluation of real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes. J Clin Microbiol. 2009;44(2):322-6.
10. Woodford N, Tierno PM, Young K, Tysall L, Palepou MI, Ward E, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A b-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004;48:4793-9.
11. Zagorianou A, Sianou E, Iosifidis E, Dimou V, Protonotariou E, Miyakis S, et al. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill. 2012;17(7):pii:20088.
12. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30(12):1180-5.
13. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108-13.
14. Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob. 2008;7:13.
15. Clinical and Laboratory Standards Institute 2011: Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Document M100-S21. Wayne, PA.
16. Landman D, Salamera J, Singh M, Quale J. Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints. J Clin Microbiol. 2011;49(11):3931-3.
17. Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, et al. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of postacute care facilities on dissemination. J Antimicrob Chemother. 2010;65:1807-18.
18. Weisenberg SA, Morgan DJ, Espinal-Witter R, Larone DH. Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem. Diagn Microbiol Infect Dis. 2009;64:233-5.
19. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenemresistant Klebsiella pneumoniae strains in an Israeli Hospital. Antimicrob. Agents Chemother. 2007;51(8):3026-9.